Overview
This lecture covers three environmental pathogens notifiable in Aotearoa New Zealand: Legionella (bacterial), Giardia (protozoan parasite) and Cryptosporidium (protozoan parasite). Each is worked through the same “chain of infection” framework (causative agent, reservoir/source, means of exit, mode of transmission, portal of entry, person at risk), covering symptoms, transmission routes, at-risk groups and the interventions that break the chain for each organism, set against NZ/Aotearoa surveillance data.
Transcription note
The lecture header on the objectives slide reads “2022” while the title slide reads “2026” [slide does not elaborate on the discrepancy]. A surveillance table’s bottom row (Hepatitis B, 2023/2024) is cut off at the slide edge. One age-distribution bar chart’s values are estimated visually since no numeric labels are given on the slide. A decorative slide of oocyst/sporozoite imagery carries no caption or label confirming what it depicts.
Chain of infection framework
The lecture uses a recurring six-segment “chain of infection” model to structure each pathogen:
- Causative agent: the pathogenic organism itself
- Reservoir/source: where the organism persists in the environment
- Means of exit: how it leaves its source/host
- Mode of transmission: how it spreads to a new host
- Portal of entry: how it enters the new host
- Person at risk: who is susceptible
Breaking the chain at any one segment (e.g. treating the agent, removing a susceptible portal of entry, protecting persons at risk) stops disease spread.
Burden in Aotearoa
ESR/Ministry of Health notification data (per 100,000, national):
- Cryptosporidiosis rose 2023→2024 (15.9 → 23.1)
- Giardiasis fell slightly (17.2 → 15.8)
- Legionellosis fell (4.6 → 3.4)
- For comparison, common notifiable diseases such as campylobacteriosis (108.7–116.6) and pertussis (2.7 → 32.7, sharp rise) are much more or more variably common
2021 total notifications by sex (female/male/total): Giardiasis 521/521/1044; Cryptosporidiosis 395/307/702; Legionellosis 58/128/186 (Legionellosis notably male-skewed, roughly 2:1).
By age band (2021, approximate): Giardiasis peaks in the 1-4 year and 30-39 year age bands; Cryptosporidiosis peaks in the 20-29 and 30-39 year age bands; Legionellosis is low across all age bands but rises steadily with age, peaking in the 60-69 year band.
Legionellosis
Causative agent: Legionella spp, Gram-negative, facultative intracellular bacteria, over 90 species. Most NZ cases are L. pneumophila and L. longbeachae; L. sainthelensi is rare. Optimal growth range 20-45°C.
Reservoir and means of exit: In water, Legionella grows and multiplies inside environmental amoebae and other freshwater protozoa, which also shelter it from adverse conditions such as extreme temperature and chlorine. In human lungs it invades and grows within alveolar macrophages, mistaking them for its natural protozoan host, causing disease.
Two clinical presentations:
| Feature | Legionnaires’ disease | Pontiac fever |
|---|---|---|
| Severity | Atypical pneumonia | Milder, influenza-like upper respiratory illness |
| Incubation | Usually 2-10 days (average 6-7) | 1-2 days |
| Prodrome | 1-2 days: mild headache, myalgia, then high fever, chills, rigors, cough | Influenza-like: myalgia, fever, headache |
| Cough | ~90% dry cough at first, may progress to productive/green/bloodstained sputum | ~50% have a cough |
| Other features | ~1/3 have dyspnoea, pleuritic chest pain, haemoptysis; ~1/3 have nausea, vomiting, diarrhoea, anorexia; altered mental status, seizures, confusion, ataxia, bradycardia can occur | Pyrexia, tachypnoea; patients look “sickly”; pericarditis, hepatomegaly, impaired mental state rare; generally self-limiting |
- Death rate ~25% if Legionnaires’ disease is untreated.
- Cannot be transmitted person to person.
Mode of transmission: Most commonly inhalation of contaminated aerosols from water sprays, jets or mists (e.g. cooling towers, hot tubs, air-conditioning, plumbing systems). Aspiration of contaminated water or ice can also cause infection, particularly in susceptible hospital patients. In NZ/Australia specifically, L. longbeachae is strongly associated with potting mix/compost (pine bark based) — a locally distinct exposure route compared to the classic aerosol/cooling-tower route.
Persons at risk: AIDS/immunocompromised patients or those on immunosuppressive drugs; advanced age and male sex (2-5x more common in men over 50); heavy smokers/long smoking history; alcohol abuse; pre-existing conditions (COPD, cancer, diabetes); end-stage chronic kidney disease; recent surgery; malignancy (lung cancer, haematologic malignancy).
Giardiasis
Causative agent: Giardia duodenalis (also called G. lamblia, G. intestinalis), a parasite.
Life cycle:
- Cysts ingested (10-25 cysts is enough) via contaminated water or food, or direct faecal-oral transmission (e.g. day-care settings).
- Excystation follows exposure to stomach acid and intestinal proteases, releasing trophozoites.
- Trophozoites multiply by binary fission and reside in the upper small bowel, adherent to enterocytes.
- Encystation occurs under conditions of changing bile salt concentration and alkaline pH in the large intestine; smooth-walled cysts can contain two trophozoites. Trophozoites themselves do not survive outside the host; cysts do survive.
- Cysts and trophozoites are passed in stool into the environment; one bowel motion can contain 100 million cysts.
Clinical progression: incubation (~1 week average), prodromal stage (1-2 days), illness (~2 weeks, with a possible fatal branch if untreated), convalescent period (duration depends on treatment, ~3 days). Symptoms: diarrhoea, gas, greasy stools that tend to float, stomach/abdominal cramps, upset stomach/nausea/vomiting, dehydration.
Chain of infection: Reservoir is animals, humans and water, with inter- and intra-species cycling of parasites between wildlife and livestock populations and the human environment (e.g. contamination of animal water sources feeding into water used by humans and domesticated animals). Means of exit is faecal excretion; mode of transmission is contaminated food/water. Portal of entry is ingestion (as few as ~10 cysts is enough).
Persons at risk: travellers to countries where giardiasis is common; people in childcare settings; close contacts of an infected person; people who swallow contaminated drinking water; backpackers/campers drinking untreated water from lakes/rivers; people in contact with infected animals; men who have sex with men.
Breaking the chain: treatment with metronidazole or tinidazole (targets the causative agent); encouraging breastfeeding (protects the person at risk); boiling drinking water, using only clean water to wash fruit, and handwashing (block the portal of entry).
Cryptosporidiosis
Classification: Cryptosporidium is an apicomplexan, in the same phylum as Plasmodium (malaria), Theileria, Babesia, Toxoplasma (toxoplasmosis) and Eimeria (coccidiosis).
Causative agent: Cryptosporidium parvum or Cryptosporidium hominis. Causes severe infection particularly in young children and people with weakened immune systems (“easy targets”). Has a simple, single-host life cycle.
Life cycle:
- Infection begins with ingestion of water or food containing spore-like oocysts.
- Cryptosporidium enters cells of the small intestine.
- Sexual reproductive stages occur within the epithelial cell layer (male and female stages, microgamete formation).
- Oocysts pass into the colon and are released in the faeces, going on to infect others.
Clinical progression: incubation ~1 week (can be as soon as 2 days), prodromal stage 1-2 days, illness ~2 weeks (with a possible fatal branch if untreated), convalescent period dependent on treatment and immune status (~30 days). Symptoms: watery diarrhoea, stomach cramps/pain, dehydration, nausea, vomiting, fever, weight loss.
Chain of infection: Reservoir is animals, humans and water; means of exit is faecal excretion; mode of transmission is contaminated food/water; portal of entry is ingestion (~30 oocysts is enough).
Risk factors (from case-control studies across developed nations, Bouzid et al., odds ratios vary considerably by location): consistently implicated factors include contact with someone who has diarrhoea (especially children under 6, OR up to ~8.6), calf/cattle contact (OR up to ~5.1), drinking unboiled/untreated water from rivers, lakes or dams (OR up to ~8.0 for swallowing untreated water), international travel (OR up to 7.7), swimming in public pools or freshwater, and visiting farms. Some factors were protective in certain locations (e.g. eating uncooked carrots or raw vegetables showed OR < 1).
Persons at risk: people with AIDS; those with inherited immune system diseases; cancer and transplant patients on immunosuppressive drugs.
Breaking the chain: treatment with nitazoxanide (causative agent); encouraging breastfeeding (person at risk); boiling drinking water, using only clean water to wash fruit, handwashing (portal of entry). The lecture notes explicitly that “nitazoxanide is not enough” — treatment alone does not fully address the disease burden, illustrated by images of affected children in low-resource clinical settings [slide does not elaborate further on what additional measures are needed].
Self-test
- Describe the six segments of the chain of infection framework used throughout this lecture.
- Distinguish Legionnaires’ disease from Pontiac fever in terms of severity and typical incubation period.
- Explain why Legionella survives well in environmental water sources, referencing its relationship with protozoa.
- Which two Legionella species cause most cases in Aotearoa, and which is rare?
- Describe the two main modes of transmission for Legionella, including the exposure route specific to NZ/Australia.
- List the groups at increased risk of severe Legionellosis.
- A patient develops fever, dry cough progressing to bloodstained sputum, altered mental status and bradycardia after a hot tub stay. Which of the two Legionella presentations does this best fit, and why?
- Describe the steps of the Giardia life cycle from ingestion of cysts to excretion.
- What is the minimum infectious dose of Giardia cysts, and how many cysts can one bowel motion release into the environment?
- List the risk groups for giardiasis.
- Describe the three interventions used to break the chain of infection for giardiasis, and state which chain segment each targets.
- Where does Cryptosporidium sit taxonomically, and name two other medically important genera in the same group.
- Describe the steps of the Cryptosporidium life cycle from ingestion to onward transmission.
- What is the minimum infectious dose of Cryptosporidium oocysts?
- List three risk factors for cryptosporidiosis identified across case-control studies, with their general direction of effect.
- Distinguish the treatment drug used for giardiasis from that used for cryptosporidiosis.
- Why does the lecture state that “nitazoxanide is not enough” for cryptosporidiosis?
- Compare Legionellosis, giardiasis and cryptosporidiosis in terms of their environmental reservoir and portal of entry, and explain why boiling water is an effective intervention for two of the three but not the third.
Answers
Reveal answers
- Causative agent (the pathogenic organism), reservoir/source (where it persists), means of exit (how it leaves its source/host), mode of transmission (how it spreads), portal of entry (how it enters a new host), and person at risk (who is susceptible).
- Legionnaires’ disease is a more severe atypical pneumonia (death rate ~25% untreated) with incubation usually 2-10 days; Pontiac fever is a milder, self-limiting influenza-like upper respiratory illness with a shorter 1-2 day incubation.
- Legionella grows and multiplies within environmental amoebae and other freshwater protozoa, which also shelter it from adverse conditions such as extreme temperature and chlorine, allowing it to persist in water systems.
- L. pneumophila and L. longbeachae cause most NZ cases; L. sainthelensi is rare.
- Most commonly, inhalation of contaminated aerosols from water sprays, jets or mists (e.g. cooling towers, hot tubs, air conditioning, plumbing); also aspiration of contaminated water or ice, particularly in susceptible hospital patients. In NZ/Australia specifically, L. longbeachae is linked to potting mix/compost (pine bark based).
- AIDS/immunocompromised patients or those on immunosuppressive drugs; advanced age and male sex (2-5x more common in men over 50); heavy smokers; alcohol abuse; COPD, cancer, diabetes; end-stage chronic kidney disease; recent surgery; malignancy.
- Legionnaires’ disease — these are the severe pneumonia-type features (progressive cough, altered mental status, bradycardia) rather than the milder influenza-like Pontiac fever picture.
- Cysts ingested (10-25) via contaminated water/food or faecal-oral contact → excystation triggered by stomach acid and intestinal proteases releases trophozoites → trophozoites multiply by binary fission, adherent to enterocytes in the upper small bowel → encystation occurs with changing bile salt concentration and alkaline pH in the large intestine → cysts (and trophozoites, which do not survive) passed in stool into the environment.
- As few as ~10 cysts can cause infection; one bowel motion can release 100 million cysts.
- Travellers to endemic countries, people in childcare settings, close contacts of infected people, people who swallow contaminated drinking water, backpackers/campers drinking untreated water, people in contact with infected animals, men who have sex with men.
- Metronidazole/tinidazole treatment targets the causative agent; encouraging breastfeeding protects the person at risk; boiling drinking water, washing fruit only in clean water, and handwashing block the portal of entry.
- Cryptosporidium is an apicomplexan; other genera in the group include Plasmodium (malaria), Theileria, Babesia, Toxoplasma and Eimeria.
- Ingestion of water/food containing oocysts → Cryptosporidium enters small intestine epithelial cells → sexual reproductive stages occur within the epithelial layer → oocysts pass into the colon and are released in faeces, going on to infect others.
- Around 30 oocysts.
- Any three of: contact with a person (especially a child under 6) with diarrhoea (higher risk); calf/cattle contact (higher risk); drinking unboiled/untreated water from rivers, lakes, dams or municipal supplies (higher risk); international travel (higher risk); swimming in pools/freshwater (higher risk); visiting farms (higher risk); eating uncooked carrots or raw vegetables (protective/lower risk in some studies).
- Giardiasis is treated with metronidazole or tinidazole; cryptosporidiosis is treated with nitazoxanide.
- The lecture flags that treatment alone does not fully resolve the disease burden [slide does not elaborate further], illustrating this with images of affected children in low-resource clinical settings, implying that broader interventions (e.g. water/sanitation measures) remain necessary alongside drug treatment.
- All three share animals/humans/water as an environmental reservoir and faecal-oral or waterborne routes of entry (ingestion for Giardia and Cryptosporidium). However, Legionella’s portal of entry is inhalation of contaminated aerosols (or aspiration), not ingestion, so boiling water — which kills the organism or its cysts/oocysts before ingestion — protects against Giardia and Cryptosporidium but does not address the aerosol-inhalation route by which Legionella is acquired.